You are here: Industry Insights > PIC

News List

Latest data of InnoCare's ICP-332 for the Treatment of Atopic Dermatitis Presented at LBA Session of 2024 AAD Chunhua Lu
March 11, 2024
Efficacy and Safety of a Highly Selective Oral TYK2/JAK1 Inhibitor, ICP-332, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II, Randomized, Placebo-Controlled Trial.
NMPA's Progress in Joining PIC/S zhulikou431/PharmaSources
July 12, 2023
This article will introduce China NMPA's progress in joining PIC/S and the latest change in GMP guideline of PIC/S respectively.
Ampicillin Sodium APIManufacturers In China PharmaSources
June 22, 2021
Ampicillin is an antibiotic. It is one of the most widely used drugs in the world to treat bacterial infections. First discovered in 1958, it started to be used commercially in 1961.
Phenotypic Screening and Target-Based Drug Discovery: Is it Time to Unite? Neeta Ratanghayra
May 27, 2020
With advancements in biomedical science, drug discovery has evolved different strategies. However, with this dramatic progress, concerns have emerged regarding the efficiency of translating these technical advances into safe and efficacious new drugs.
China Disclosed Research Data of PiCoVacc, an Inactivated Virus Vaccine against COVID-19 CPhI.CN
April 21, 2020
On April 19, the Chinese Academy of Medical Sciences uploaded an article entitled "Rapid development of an inactivated vaccine for SARS-CoV-2" in BioRxiv.
InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China PharmaSources
November 15, 2024
InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China
iotaSciences Launches New isoPick™ Single-Cell Picker to Further Expand Handling Solutions for Efficient Cell Biology & Gene Therapy Applications PharmaSources
February 07, 2023
First isoPick™ showcases at upcoming ELRIG CRISPR IN DRUG DISCOVERY 2023 event in Oxford (UK) and SLAS 2023 meeting in San Diego (USA).
FDA Approves Rinvoq for Treatment of Atopic Dermatitis drugs.com
January 19, 2022
The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe...
How Modeling Was Used to Support the FDA Approval of a Topical Generic Drug Product FDA
January 07, 2022
CDER Researchers have been investigating how pharmacokinetic (PK) modeling can support a determination of bioequivalence (BE) for topical drug products.
Stopping dementia at the nose with combination of rifampicin and resveratrol WorldPharmaNews
December 29, 2021
Dementia is thought to occur when proteins called amyloid-β, tau, and α-synuclein accumulate in the brain and form oligomers. A research group from the Department of Translational Neuroscience...